Mutation rate in hepatitis C virus NS3 protease is not influenced by HIV-1 protease inhibitor therapy. | AIDS;22(13): 1694-6, 2008 Aug 20. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Mutation rate in hepatitis C virus NS3 protease is not influenced by HIV-1 protease inhibitor therapy.

Halfon, Philippe; Bourlière, Marc; Khiri, Hacène; Pénaranda, Guillaume; Martineau, Agnes; Oulès, Valérie; Courcambeck, Jérôme; Philibert, Patrick.

AIDS ; 22(13): 1694-6, 2008 Aug 20.

Article in En | MEDLINE | ID: mdl-18670239

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV Protease / Viral Nonstructural Proteins / HIV Protease Inhibitors / Mutation Limits: Humans Language: En Journal: AIDS Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2008 Document type: Article Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV Protease / Viral Nonstructural Proteins / HIV Protease Inhibitors / Mutation Limits: Humans Language: En Journal: AIDS Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2008 Document type: Article Country of publication: